January 4, 2019 06:24 AM EST
Financing

Deal-hun­gry Ver­i­ly se­cures $1B in fresh fund­ing, months af­ter press­ing pause on smart lens project

Natalie Grover

Reporter

Rough­ly two years af­ter procur­ing its first out­side in­vest­ment, Ver­i­ly — the pro­lif­ic deal-mak­ing life sci­ences unit of Al­pha­bet — has se­cured $1 bil­lion in fresh funds …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Prasad again over­rode FDA vac­cine re­view­ers, this time on Mod­er­na’s Covid shot for young kids

Mer­ck­'s PD-1xVEGF part­ner LaNo­va gets snapped up for $951M

The Trump ad­min­is­tra­tion dis­band­ed a new­born screen­ing pan­el. Ad­vo­cates now face a hard­er path

FDA ques­tions safe­ty, ef­fi­ca­cy of GSK's Blenrep in mul­ti­ple myelo­ma ahead of ad­comm

Ot­su­ka buys im­munol­o­gy drugs; JCR, Acu­men team up on Alzheimer’s pro­gram

BMS warns against ‘in­dis­crim­i­nate use’ of rene­go­ti­a­tions as CMS plans next drug price talks

A service from the Financial Times